Patients Stopping Weight-Loss Medications Put On Weight Four Times Faster Compared to Those on Conventional Diets

Fresh analysis suggests that patients who come off new slimming jabs like Wegovy and Mounjaro can put back on shed pounds much more quickly than those who stop conventional lifestyle regimens.

Research printed in a prominent medical journal shows that while obese individuals frequently drop a large proportion of their body weight while undergoing treatment, the mass comes back at an estimated rate of nearly a kilo each month once they quit.

"Individuals using these medications need to be aware of the potential of fast rebound weight gain when the therapy is stopped," cautioned expert Dr. Susan Jebb.

This pace of regain implies a reversion to original mass within about a year and a half.

Comparing Therapies

The study, which examined dozens of studies involving over 9,000 of patients, compared the outcomes of the injectable medications with other pills.

Scientists emphasize that individuals who shed pounds through diet and exercise typically have a slower creep back—around 100 grams monthly—once they finish.

The Reason for the Fast Regain

Nutrition scientists believe the mode of action of the jabs accounts for the amplified rebound.

GLP-1 drugs copy a body's own chemical called GLP-1, which controls appetite.

"Sustained high doses of the hormone levels several times higher than the body's typical production may cause the system to produce less of its endogenous hormone, and could reduce sensitivity to its effects," explained Dr. Adam Collins, a dietetics expert.

"Stopping of this GLP-1 'fix' leads to hunger is uncontrolled, making overeating a significant risk."

A Lifelong Condition?

Medical guidelines advise the injections for people with weight-linked medical conditions, alongside recommended lifestyle changes.

Professionals argue that, considering the significant potential of weight regain, the therapy should be considered ongoing.

This perspective is supported by pharmaceutical companies, who state that the results "emphasize the long-term nature of obesity," similar to managing conditions like diabetes.

User Experiences

People who have come off the medication report a intense return of appetite.

"It was like a switch activating and you're instantly ravenous," described an individual.

This challenge is exacerbated if patients have not adopted lasting lifestyle or habit modifications during therapy.

Significant Adoption

Survey data suggest that a significant number of adults in the UK have tried weight-loss jabs in the past year, with desire remaining high.

• Adoption is greater among women compared to men.
• The middle-aged demographic shows the highest level of interest.
• A large proportion access the drugs through private healthcare rather than public health services.

Finally, researchers emphasize that while the jabs are potent agents for weight loss, they are not a standalone cure and maintained weight loss likely depends on ongoing lifestyle management.